Samuel Volchenboum to Prospective Studies
This is a "connection" page, showing publications Samuel Volchenboum has written about Prospective Studies.
Connection Strength
0.158
-
Childhood cancer predisposition study: a prospective registry and biorepository protocol. BMJ Open. 2026 08 05; 16(8):e120576.
Score: 0.032
-
Lynch syndrome integrative epidemiology and genetics (LINEAGE): rationale for cohort design. Fam Cancer. 2026 05 06; 25(2).
Score: 0.031
-
Impact of First-of-Its-Kind Patient-Facing Pharmacogenetics Tool on Dosing Decisions and Treatment Outcomes. Clin Pharmacol Ther. 2025 10; 118(4):906-916.
Score: 0.030
-
Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe. Eur J Cancer. 2022 09; 172:367-386.
Score: 0.024
-
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer. Nat Med. 2022 08; 28(8):1581-1589.
Score: 0.024
-
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing. Clin Pharmacol Ther. 2017 Nov; 102(5):859-869.
Score: 0.017